
The author analyzes the requirements for the models applied in the screening of immunotropic agents. Reviews the characteristics of the screening of such substances. Suggests a variant to be used in the system of screening the immunotropic drugs.
Immunity, Cellular, Time Factors, Dose-Response Relationship, Drug, Lymphoid Tissue, T-Lymphocytes, Dose-Response Relationship, Immunologic, Drug Evaluation, Preclinical, Immunity, Antigen-Antibody Reactions, Disease Models, Animal, Adjuvants, Immunologic, Research Design, Animals, Immunosuppressive Agents
Immunity, Cellular, Time Factors, Dose-Response Relationship, Drug, Lymphoid Tissue, T-Lymphocytes, Dose-Response Relationship, Immunologic, Drug Evaluation, Preclinical, Immunity, Antigen-Antibody Reactions, Disease Models, Animal, Adjuvants, Immunologic, Research Design, Animals, Immunosuppressive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
